Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board
Digital Health Global
JUNE 20, 2023
With the additional funding and board appointments, we are set to accelerate the validation of our approach by advancing multiple programs and partnerships toward the ultimate test of any biopharma technology platform – human clinical trials.” Jane Rhodes, Ph.D., Bernd Seizinger, M.D., and Europe. Daniel Veres, M.D.,
Let's personalize your content